Hematological toxicity is the most common adverse event after chimeric antigen receptor
(CAR) T-cell therapy. Cytopenias can be profound and long-lasting and can predispose for …

Aplastic Anemia | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …

PURPOSE Patients with relapsed or refractory T-cell acute lymphoblastic leukemia (r/r T-
ALL) have few options and poor prognosis. The aim was to assess donor-derived anti-CD7 …

The management of perioperative bleeding involves multiple assessments and strategies to
ensure appropriate patient care. Initially, it is important to identify those patients with an …

Autologous T cells engineered to express chimeric antigen receptor against the B cell
antigen CD19 (CAR19) are achieving marked leukemic remissions in early-phase trials but …

Purpose To provide evidence-based guidance on the use of platelet transfusion in people
with cancer. This guideline updates and replaces the previous ASCO platelet transfusion …

Purpose To provide healthcare professionals with clear guidance on situations when the
use of irradiated blood components is indicated. The term 'blood component'means the …

Recent combat experience reignited interest in transfusing whole blood (WB) for patients
with life‐threatening bleeding. US Army data indicate that WB transfusion is associated with …

Whole blood: back to the future : Current Opinion in Hematology Whole blood: back to the
future : Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe Get …

Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention - Critical
Care Nursing Clinics Skip to Main Content Skip to Main Menu Advertisement Critical Care …